peplexicon
Choose your depth

Context, anatomy, and key evidence

← Peptide library

antioxidant tripeptide

Glutathione

Published evidence · coverage incomplete
Anatomical contextAnatomy connections are not mapped yet.

No body region is highlighted until this profile has a supported anatomical connection. This does not mean the peptide has no biological effects.

Read published mechanism findings ↓

At a glance

What is it—and why does it matter?

The reported kred quantifies the reaction rate for oxoMn(IV) reduction; glutathione’s kred was 130000.0 M-1 s-1 in this assay. pKa is the acid dissociation constant on a log scale; here, glutathione’s pKa was measured as 8.75.

Sources for this introduction: [1] [2]

This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.

What is it?

A molecule, not a product name.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

How does it work?

Target, response, and disposition.

Mechanism

The reported kred quantifies the reaction rate for oxoMn(IV) reduction; glutathione’s kred was 130000.0 M-1 s-1 in this assay.

Reported result
kred = 130000.0 M-1 s-1
Source records
1
Independent studies
1

Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.

Exact passages, locators, and provenance
  1. supports · Source-backed record
    Molecule: CHEMBL1543 Target: ADMET (CHEMBL612558) Assay: The compound was evaluated for the rate of oxoMn (IV) reduction Assay format: assay format Standard result: kred = 130000.0 M-1 s-1 Document: CHEMBL1129224

    ChEMBL activities for CHEMBL1543 · Activity 267700

    chembl-activities:chembl1543:cc9464d448d3:cc9464d448d3

Pharmacokinetics

pKa is the acid dissociation constant on a log scale; here, glutathione’s pKa was measured as 8.75.

Reported result
pKa = 8.75
Source records
1
Independent studies
1

Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.

Exact passages, locators, and provenance
  1. supports · Source-backed record
    Molecule: CHEMBL1543 Target: No relevant target (CHEMBL2362975) Assay: pKa value was determined Assay format: small-molecule physicochemical format Standard result: pKa = 8.75 Document: CHEMBL1134179

    ChEMBL activities for CHEMBL1543 · Activity 470001

    chembl-activities:chembl1543:cc9464d448d3:cc9464d448d3

What has been studied?

What the evidence says.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Risks and interactions

Risks, organized for scanning.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Products and regulatory status

Same ingredient. Different records.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Administration context

The practical clinical context.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Research status + gaps

What still needs better answers?

  • No publishable claim yet for: administration, contraindication, effect, identity, interaction, regulatory, safety
  • 29 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (22), assurance_score_below_0.72 (6), current_regulatory_source_required (5), extraction_ambiguity (26), high_risk_requires_regulatory_or_two_independent_sources (6), no_direct_support (27)

These are the limits of this profile, not an exhaustive list of scientific uncertainties.

References + discovery

Open the records yourself.

  1. ChEMBL activities for CHEMBL1543

    chembl-activities · published 2026-08-27 · retrieved 2026-08-27T19:16:08Z

Publication history and provenance

Version 3 · Automated assessment · 2026-08-27T19:16:08Z

69c96dda1483d50df3eec9f739a0b8bf9e4926e18dba660e5ba349766862dc73